Common Contracts

First amendment to collaboration and option agreement for

Collaboration and Option Agreement • July 14th, 2024 • New York

• Contract Type
  Collaboration and Option Agreement
• Filed
  July 14th, 2024
• Jurisdiction
  New York

Akcea Therapeutics and Ionis Pharmaceuticals announced that Novartis has exercised its option to license AKCEA-APO(a)-LRx, a drug to treat patients with elevated levels of lipoprotein(a), or Lp(a), and established cardiovascular disease (CVD).